Medicine for treating hemorrhagic apoplexy

Abstract

The invention provides a medicine for treating hemorrhagic apoplexy. The medicine for treating the hemorrhagic apoplexy is obtained by screening thyme herb, herba chelidonii, radix rhodomyrti, creeping dichondra herb, Chinese wolfberry fruit, adhatoda ventricosa, rhizoma polygonati, radix moridae officinalls, sweet wormwood herb, airpotato yam rhizomes and the like from a large quantity of Chinese herbal medicine ingredients and optimizing the using amount and combination. On the basis, it makes clear that the medicine has the exact treatment effect on the hemorrhagic apoplexy through an experimental means, and it is proved that neurological deficits and deterioration can be reduced by inhibiting immune cells from entering the brain in the acute period, and the effect is achieved in the mode that by inhibiting the regulating, controlling and maintaining functions of encephalic immune cells on an inflammation environment, inflammations are inhibited, and secondary pathological damage of the inflammations in the acute period is reduced. According to the medicine, the superior technical effect is achieved through the innovative technical means, the cost is low, and achievement is easy, so that the good application prospect is achieved.

Description

technical field [0001] The invention relates to the technical field of neurology, in particular to a medicine for treating hemorrhagic stroke. Background technique [0002] Hemorrhagic stroke, also known as cerebral hemorrhage, refers to the bleeding caused by the rupture of blood vessels in the non-traumatic brain parenchyma, accounting for 20% to 30% of all strokes. Blood lipids, diabetes, high blood pressure, vascular aging, smoking and so on are closely related. Patients with cerebral hemorrhage often develop sudden onset due to emotional agitation and exertion, and have a high early mortality rate. Most of the survivors have sequelae such as motor disorders, cognitive impairments, and speech and swallowing disorders to varying degrees. [0003] For this disease, conventional means of treatment in the prior art is surgical therapy and drug supportive therapy. Among them, surgical therapy is an effective treatment method generally recognized in the technical field. Howe...

AI Technical Summary

Problems solved by technology

[0004] The present invention aims at the technical defects of the prior art, and provides a drug for treating hemorrhagic stroke, so as to solve the technical problem of the lack of drug treatment means for the disease in the prior art

Images